RE:RE:RE:RE:RE:NominationThanks for the nomination Palin but since I am still not to the last stage of grief, I would likely only cause a unhealthy disturbance if I were granted the opportunity to ask questions, which will never happen for any of us anyway.
It is quite unfortunate that the analyst coverage on THTX is so weak and, even worse, is getting weaker. Given the phase III NASH and now Fasat Tracked phase I cancer, you would think it should not be too hard to find a number of analysts to cover the stock. Not being able to do so has cost us dearly and then the deal seemed to be constructed in a way to make sure the leverage of a deal to attract analyst coverage was totally squandered. Given the choices that are being made, is it any wonder the quarterly calls, let alone the company altering call on the company's decision to pursue the general NASH market, get no real interest from the institutional investment community. How long can this go on without being addressed???? Substandard/inadequate/disinterested analyst coverage of TH has been a standard feature for a very long time.
The deal showed us that we believe more in TH's prospects than TH leadership does. Until that attitude changes, it is hard to see the quarterly conference calls becoming very vibrant or attracting a higher level of analytical talent.
palinc2000 wrote: Quaterly CCs s should last more than a few minutes ...Having 2 uninterested sell side analysts mostly asking one or two questions benefit no one..
scarlet1967 wrote: What CYDY is doing is working anyway I am going to schedule a call with Leah discussing their marketing and communication strategies. I won't discuss the deal as they did give their rationale justifying it earlier and I don't think she will be adding anything meaningful re the deal.
I just want to see how open they are to approach a more retail friendly approach.
palinc2000 wrote: Questions from investors are frequently allowed during Investors Day and it seems to me that having a representative of a Fund holding more than 6 million shares and an investor with your background would help not only other investors but also the Company....They could make whatever rules they want
Wino115 wrote: They've never let anyone other than sell-side analysts ask questions. I don't think that will change anytime soon and seems to be standard now given some of the crazy histrionics past calls on other controversial stocks had. I guess the lawyers have just decided it's better to shut it off for the general public. Only guys like Cytodyn let anyone ask a question, but that's because no sell side would associate with them.
palinc2000 wrote: I hereby nominate Spceo1 and Wino as representatives pf posters on this MB to ask questions during the Theratech 's CC s
All those in favor please vote
PS Of course I presume that both nominees are willing to act on our behalf